Pharmaceutical

Gilead, CHAI and Penta to enhance HIV treatment for children

Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.

Jul 15, 2023 - 20:00
Gilead, CHAI and Penta to enhance HIV treatment for children
Gilead Sciences has entered into collaborations with CHAI and Penta ID network to expedite the development of dispersible HIV treatments.
Read the original article

Tags:

Previous Article

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Next Article

Health Canada approves AstraZeneca-Merck’s prostate cancer therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA lifts two-year clinical hold on CytoDyn’s HIV trial

FDA lifts two-year clinical hold on CytoDyn’s HIV trial

Mar 1, 2024

STAT+: Obscure vertigo drug could bring rare hope for patients with devastating neuron disease

STAT+: Obscure vertigo drug could bring rare hope for p...

Feb 1, 2024

STAT+: GOP senator probes drug discount programs at Cleveland Clinic, Bon Secours

STAT+: GOP senator probes drug discount programs at Cle...

Sep 28, 2023